Traxis Partners’s Novartis NVS Stock Holding History

Traxis Partners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-27,900	Closed	-$1.77M	–	26
2013 Q2	$1.77M	Buy	+27,900	New	+$1.82M	1.37%	39

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Traxis Partners's NVS Position: Q3 2013 in Review

Traxis Partners sold out of Novartis (NVS) in Q3 2013, closing a stake of 27,900 shares — an estimated $1.77M sold.

Traxis Partners first reported a position in NVS in Q2 2013 and held it in 1 quarter. The position peaked at $1.77M in Q2 2013. 761 funds tracked by Wall St. Rank hold NVS as of Q3 2013.

Traxis Partners reported no remaining Novartis position as of Q3 2013 after selling out during the quarter.
Traxis Partners sold 27,900 Novartis shares in Q3 2013, an estimated $1.77M.
Traxis Partners first reported a position in Novartis in Q2 2013 and held it in 1 quarter.
Traxis Partners's Novartis position peaked at $1.77M in Q2 2013.
761 funds tracked by Wall St. Rank held Novartis as of Q3 2013.

Based on Traxis Partners's 13F filing for Q3 2013.